XML 20 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Shareholders Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Beginning balance at Dec. 31, 2018 $ 10,604.7 $ 3.8 $ 985.9 $ 11,064.7 $ (1,657.1) $ 207.4
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2018   385,500,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) (150.9)     (146.4) (8.3) 3.8
Stock Issued During Period, Shares, Restricted Stock Award, Gross   400,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (5.1)   (5.1)      
Stock based compensation 25.0   25.0      
Stock Repurchased During Period, Value $ (124.5)   (124.5)      
Stock Repurchased During Period, Shares (5,800,000)          
Dividends $ (38.2)     (38.2)    
Dividends for noncontrolling interests (0.4)         (0.4)
Ending balance at Sep. 30, 2019 10,311.2 $ 3.8 881.3 10,880.7 (1,665.4) 210.8
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2019   380,100,000        
Beginning balance at Jun. 30, 2019 10,682.3 $ 3.8 1,002.9 10,944.2 (1,477.9) 209.3
Common stock shares outstanding, beginning balance (in shares) at Jun. 30, 2019   385,900,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) (230.0)     (44.1) (187.5) 1.6
Stock based compensation 2.9   2.9      
Stock Repurchased During Period, Value $ (124.5)   (124.5)      
Stock Repurchased During Period, Shares (5,800,000)          
Dividends $ (19.4)     (19.4)    
Dividends for noncontrolling interests (0.1)         (0.1)
Ending balance at Sep. 30, 2019 10,311.2 $ 3.8 881.3 10,880.7 (1,665.4) 210.8
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2019   380,100,000        
Beginning balance at Dec. 31, 2019 $ 9,367.6 $ 3.8 858.4 9,921.5 (1,598.2) 182.1
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2019 378,764,442 378,800,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) $ (627.6)     (161.8) (455.6) (10.2)
Stock Issued During Period, Shares, Restricted Stock Award, Gross   300,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (2.7)   (2.7)      
Stock based compensation 5.5   5.5      
Dividends (38.1)     (38.1)    
Dividends for noncontrolling interests (0.5)         (0.5)
Ending balance at Sep. 30, 2020 $ 8,704.2 $ 3.8 861.2 9,721.6 (2,053.8) 171.4
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2020 379,090,013 379,100,000        
Beginning balance at Jun. 30, 2020 $ 8,663.7 $ 3.8 855.4 9,747.0 (2,113.2) 170.7
Common stock shares outstanding, beginning balance (in shares) at Jun. 30, 2020   379,100,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) 54.1     (6.2) 59.4 0.9
Stock based compensation 5.8   5.8      
Dividends (19.2)     (19.2)    
Dividends for noncontrolling interests (0.2)         (0.2)
Ending balance at Sep. 30, 2020 $ 8,704.2 $ 3.8 $ 861.2 $ 9,721.6 $ (2,053.8) $ 171.4
Common stock shares outstanding, ending balance (in shares) at Sep. 30, 2020 379,090,013 379,100,000